ERBB2 and breast cancer: IHC statistical analysis revealed that high expression of ADAM10 was positively associated with shorter RFS and OS (Supplemental Figure 7D), and that ADAM10 expression correlated positively with DPAGT1 level in the 170 HER2+ breast cancer specimens (Supplemental Figure 7E).